What is Aumet?
Aumet operates as a sophisticated B2B digital platform designed to bridge the gap between pharmaceutical manufacturers, distributors, pharmacies, and healthcare providers. By functioning as an AI-driven healthcare marketplace and procurement system, the company effectively streamlines complex ordering processes, supply chain coordination, and inventory management. Its platform serves as a vital conduit for data exchange, providing real-time decision support that significantly improves medicine availability and reduces operational friction within the medical ecosystem. Through its focus on digitizing pharmaceutical procurement, Aumet is building a scalable, transparent infrastructure that addresses the unique challenges of healthcare commerce in emerging markets.
How much funding has Aumet raised?
Aumet has raised a total of $12M across 1 funding round:
Series A
$12M
Series A (2026): $12M with participation from Emkan Capital, Qatar Development Bank, Shorooq Partners, and Right Side Capital Management
Key Investors in Aumet
Emkan Capital
Emkan Capital is an investment firm focused on mentoring and investing in early-stage technology companies in the MENA region, providing growth capital and access to global co-investors.
Qatar Development Bank
Qatar Development Bank is dedicated to supporting the growth and diversification of businesses in Qatar, offering comprehensive resources to foster a thriving entrepreneurial environment.
Shorooq Partners
Shorooq Partners is a leading alternative investments manager in the MENA region, specializing in venture capital and private credit to fuel the growth of visionary founders.
What's next for Aumet?
With the successful closure of this major strategic investment, Aumet is poised to deepen its technological moat and expand its footprint in the healthcare logistics space. The company's strategic roadmap likely involves scaling its AI-driven procurement engine to handle higher transaction volumes and integrating more advanced predictive analytics to further optimize supply chain transparency. As it continues to build out its digital infrastructure, Aumet is expected to focus on strengthening its partnerships with regional stakeholders and enhancing its value proposition for healthcare providers. This capital deployment will be critical in maintaining its competitive edge as it navigates the complexities of the pharmaceutical supply chain and works toward achieving long-term operational sustainability.
See full Aumet company page
